Skip to content

Clinical trials

Phase 1 Carcinoma, Renal Cell trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1 Country / region: Japan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20153
20161
20181
20191
20203
20212
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated7
Active, not recruiting4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Pfizer5
GlaxoSmithKline2
AbbVie1
Bayer1
Calico Life Sciences LLC1
Daiichi Sankyo1
Eisai Co., Ltd.1
Telix Pharmaceuticals (Innovations) Pty Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell19
Carcinoma, Non-Small-Cell Lung11
Neoplasms8
Squamous Cell Carcinoma of Head and Neck8
Melanoma6
Colorectal Neoplasms5
Ovarian Neoplasms4
Kidney Neoplasms3
Neoplasm Metastasis3
Stomach Neoplasms3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.